Medical Imaging Department, Gold Coast University Hospital (Queensland Health), Southport, Australia.
Department of Cardiothoracic Surgery, The Prince Charles Hospital (Queensland Health), Brisbane, Australia.
Am Heart J. 2023 Jul;261:21-34. doi: 10.1016/j.ahj.2023.03.004. Epub 2023 Mar 18.
The use of F-FDG PET/CT in diagnostic algorithms for PVE has increased since publication of studies and guidelines advocating its use. The assessment of test accuracy has been limited by small study sizes. We undertook a systematic review using individual patient data (IPD) meta-analysis techniques.
To estimate the summary sensitivity and specificity of F-FDG PET/CT in diagnosing PVE. We also assessed the effect of patient factors on test accuracy as defined by changes in the odds ratios associated with each factor. The effect of the PET/CT study on the final diagnosis was also assessed when compared to the preliminary Duke classification to determine in which patient group F-FDG PET/CT had the greatest utility.
Studies were included if PET/CT was performed for suspicion of PVE and IPD of both the PET/CT result and final diagnosis defined by a gold-standard assessment was available. There were 3 possible final diagnoses ("definite PVE," "possible PVE," and "rejected PVE").
Seventeen studies were included with IPD available for 537 patients (from 538 scans). The summary sensitivity and specificity were 85% (95% CI 74.2%-91.8%) and 86.5% (95% CI 75.8%-92.9%) respectively when patients with final diagnosis of "possible PVE" were classified as positive for PVE. When this group was classified as negative for PVE, sensitivity was 87.4% (95% CI 80.4%-92.1%) and specificity was 84.9% (95% CI 71.5%-92.6%). Patients with a known pathogen (especially coagulase negative staphylococcal species), elevated CRP, a biological or aortic valve infection appeared more likely to have an accurate PET/CT diagnosis. Those with a mechanical valve, prior antibiotic treatment or a transcatheter aortic valve replacement valve were less likely to have an accurate test. Time since valve implantation and the presence of surgical adhesive did not appear to affect test accuracy. Of the patients with a preliminary Duke classification of "possible PVE," 84% received a more conclusive final diagnosis of "definite" or "rejected" PVE after the PET/CT study.
F-FDG PET/CT has high sensitivity and specificity in diagnosing PVE and the diagnostic utility is greatest in patients with a preliminary Duke classification of "possible PVE." Some patient factors appear to affect test accuracy, though these results should be interpreted with caution given low patient numbers for subgroup analyses.
自发表支持 F-FDG PET/CT 用于诊断 PVE 的研究和指南以来,在 PVE 的诊断算法中使用 F-FDG PET/CT 有所增加。由于研究规模较小,对检测准确性的评估受到限制。我们进行了一项系统评价,使用了个体患者数据(IPD)荟萃分析技术。
估计 F-FDG PET/CT 诊断 PVE 的综合敏感性和特异性。我们还评估了患者因素对检测准确性的影响,方法是改变与每个因素相关的优势比。还评估了 PET/CT 研究与初步 Duke 分类之间的差异,以确定在哪些患者群体中 F-FDG PET/CT 具有最大的效用。
如果进行 PET/CT 是为了怀疑患有 PVE 并且可以获得 PET/CT 结果和最终诊断的个体患者数据(通过黄金标准评估确定),则纳入研究。最终诊断有 3 种可能的结果(“明确的 PVE”、“可能的 PVE”和“排除的 PVE”)。
共纳入 17 项研究,其中 537 例患者(来自 538 次扫描)可获得 IPD。当将最终诊断为“可能的 PVE”的患者归类为 PVE 阳性时,综合敏感性和特异性分别为 85%(95%CI 74.2%-91.8%)和 86.5%(95%CI 75.8%-92.9%)。当将此组归类为 PVE 阴性时,敏感性为 87.4%(95%CI 80.4%-92.1%),特异性为 84.9%(95%CI 71.5%-92.6%)。患有已知病原体(尤其是凝固酶阴性葡萄球菌)、CRP 升高、生物或主动脉瓣感染的患者更有可能获得准确的 PET/CT 诊断。患有机械瓣、既往抗生素治疗或经导管主动脉瓣置换瓣的患者不太可能获得准确的检查结果。植入瓣膜后的时间和手术用胶的存在似乎不会影响检测的准确性。在初步 Duke 分类为“可能的 PVE”的患者中,84%在 PET/CT 研究后获得了更明确的最终诊断“明确”或“排除”PVE。
F-FDG PET/CT 对诊断 PVE 具有高敏感性和特异性,在初步 Duke 分类为“可能的 PVE”的患者中,其诊断效用最大。一些患者因素似乎会影响检测的准确性,但由于亚组分析的患者数量较少,因此应谨慎解释这些结果。